Dr. Mark Schiller, Founder and Medical Director of the MindTherapy Clinic is helping to prove that referenced-EEG “(rEEG)” guided pharmacotherapy represents an easy, relatively inexpensive, objective office procedure that builds upon clinical judgment to guide antidepressant medication choice.” In partnership with his co-authors and researchers at Stanford, Harvard, Rush University, UC Irvine, and others, Dr. Schiller’s research showed that patients with treatment resistant depression whose prescribing was guided by the rEEG improved at a statistically significant rate over control subjects whose treatment decisions were driven by the National Institute of Health’s treatment protocol known as STAR*D, an industry standard.